Anti-tumor effect of 5-aza-2'-deoxycytidine by inhibiting telomerase activity in hepatocellular carcinoma cells

doi:10.3748/wjg.v18.i19.2334

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 19

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4989)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-8) series, Tables (1-1) series.

Item

Count

PDF

374

HTML

4307

Figures (1-8)

167

Tables (1-1)

141

Sum=4989

May 21, 2012 (publication date) through Apr 27, 2024

Times Cited of This Article

Times Cited (23)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. May 21, 2012; 18(19): 2334-2343
Published online May 21, 2012. doi: 10.3748/wjg.v18.i19.2334

Full Size Figure Download Figure

Figure 4 Methylation of telomerase reverse transcriptase promoter in 5-aza-2’-deoxycitidine-treated hepatocellular carcinoma cell lines SMMC-7721 (A) and HepG2 (B). M: Methylation; U: Unmethylation; PC: Positive control; DAC: 5-aza-2’-deoxycitidine.

Citation: Tao SF, Zhang CS, Guo XL, Xu Y, Zhang SS, Song JR, Li R, Wu MC, Wei LX. Anti-tumor effect of 5-aza-2'-deoxycytidine by inhibiting telomerase activity in hepatocellular carcinoma cells. World J Gastroenterol 2012; 18(19): 2334-2343
URL: https://www.wjgnet.com/1007-9327/full/v18/i19/2334.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i19.2334